An executive committee appointed by the board of directors will undertake Rowland’s responsibilities until a replacement is appointed.
Chris Rowland was appointed chief executive officer of Medigus in October 2013 and has since played a key role in the development and commercialization of the company’s products. “On behalf of the entire board, I want to thank Chris Rowland for his contribution to Medigus over the past five years and commend him for acting always with the highest personal and professional integrity,” said Prof. Benad Goldwasser, chairman of the board of directors. “Given his dedication to Medigus, it is no surprise that Chris intends to continue to support the company’s activity.”
“It has been an honor to work at Medigus for the past years and I look forward to working with the board of directors to identify new opportunities for the company’s products,” said Rowland.